IL6 and graft versus host disease: For instance, interleukin-6 (IL-6) is defined as an inflammation-driven marker in preclinical mechanistic studies of GVHD; in clinical cohort studies, however, it is classified as a diagnostic marker for ocular graft-versus-host disease (oGVHD)—such classification discrepancies impede the integration of cross-study data.